Drugs / ACTH
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00947895 Comparator | Oct 2009 → Jan 2011 | multiple sclerosis | Neurologique Foundation, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00947895 ↗ |
| Route | Intramuscular | “Intramuscular (IM) ACTH 80 mg/day for 5 days.” NCT00947895 ↗ |